MGRX Earnings

Quarterly EPS
$-1.37
Q2 2024
$-1.14
Q3 2024
$-0.75
Q4 2024
$-1.12
Q1 2025
$-0.57
Q2 2025
$-0.69
Q3 2025
$-0.21
Q4 2025
$-0.22
Q1 2026
Latest Revenue67.9K
Latest Net Income-3403141
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2026-$0.2267.9K-3403141-37.9%+80.4%
Q4 2025-$0.2194.4K-2769370-10.3%+72.0%
Q3 2025-$0.6984.2K-7618776-36.8%+39.5%
Q2 2025-$0.57168.1K-5415820+3.0%+58.4%
Q1 2025-$1.12109.3K-4839489-48.9%+25.3%
Q4 2024-$0.75105.2K-1948596-56.9%+58.1%
Q3 2024-$1.14133.4K-1999694-45.6%+32.9%
Q2 2024-$1.37163.2K-2391319+15.5%+34.8%
Q1 2024-$1.50214.1K-2367617
Q4 2023-$1.79244.4K-2568047
Q3 2023-$1.70245.2K-1799460
Q2 2023-$2.10141.2K-2284025
Mangoceuticals (MGRX) — Earnings